Literature DB >> 1933600

Role of oestrogen in the development of osteoporosis.

T C Hillard1, J C Stevenson.   

Abstract

The evidence now strongly supports a central role for oestrogen in the maintenance of the normal female skeleton. Loss of endogenous oestrogen leads to a period of accelerated bone loss which can be prevented with appropriate oestrogen replacement. The route of administration is not important provided adequate dosages are prescribed. Oestrogens may exert their actions by a direct steroid receptor mechanism or via local and/or systemic factors such as cytokines, prostaglandins or calcitonin. As the requirement for osteoporosis prevention grows, it is essential that the extent of the involvement oestrogen has in skeletal homeostasis is fully recognized.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933600     DOI: 10.1007/bf02555090

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  44 in total

1.  Nasal calcitonin for treatment of established osteoporosis.

Authors:  K Overgaard; B J Riis; C Christiansen; J Pødenphant; J S Johansen
Journal:  Clin Endocrinol (Oxf)       Date:  1989-04       Impact factor: 3.478

2.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.

Authors:  B S Komm; C M Terpening; D J Benz; K A Graeme; A Gallegos; M Korc; G L Greene; B W O'Malley; M R Haussler
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

3.  Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis?

Authors:  H M Taggart; C H Chesnut; J L Ivey; D J Baylink; K Sisom; M B Huber; B A Roos
Journal:  Lancet       Date:  1982-02-27       Impact factor: 79.321

4.  Bone remodeling in response to in vivo fatigue microdamage.

Authors:  D B Burr; R B Martin; M B Schaffler; E L Radin
Journal:  J Biomech       Date:  1985       Impact factor: 2.712

5.  Menopausal changes in bone remodeling.

Authors:  R P Heaney; R R Recker; P D Saville
Journal:  J Lab Clin Med       Date:  1978-12

6.  Estrogen therapy arrests bone loss in elderly women.

Authors:  M E Quigley; P L Martin; A M Burnier; P Brooks
Journal:  Am J Obstet Gynecol       Date:  1987-06       Impact factor: 8.661

7.  Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.

Authors:  J C Stevenson; G Abeyasekera; C J Hillyard; K G Phang; I MacIntyre; S Campbell; P T Townsend; O Young; M I Whitehead
Journal:  Lancet       Date:  1981-03-28       Impact factor: 79.321

8.  Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females.

Authors:  C Christiansen; M S Christensen; P McNair; C Hagen; K E Stocklund; I Transbøl
Journal:  Eur J Clin Invest       Date:  1980-08       Impact factor: 4.686

9.  Prostaglandin production by calvariae from sham operated and oophorectomized rats: effect of 17 beta-estradiol in vivo.

Authors:  J H Feyen; L G Raisz
Journal:  Endocrinology       Date:  1987-08       Impact factor: 4.736

10.  Effect of sex hormones on bone in primary osteoporosis.

Authors:  B L Riggs; J Jowsey; P J Kelly; J D Jones; F T Maher
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

View more
  3 in total

1.  Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study.

Authors:  Giovanni Corrao; Antonella Zambon; Federica Nicotra; Valentino Conti; Rossella E Nappi; Luca Merlino
Journal:  Br J Clin Pharmacol       Date:  2007-10-22       Impact factor: 4.335

2.  The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.

Authors:  I Kyvernitakis; K Kostev; T Nassour; F Thomasius; P Hadji
Journal:  Osteoporos Int       Date:  2016-07-26       Impact factor: 4.507

3.  Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group.

Authors:  K Michaëlsson; J A Baron; B Y Farahmand; O Johnell; C Magnusson; P G Persson; I Persson; S Ljunghall
Journal:  BMJ       Date:  1998-06-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.